closed loop stimulation

R&D

Increasingly, electrophysiologists are exploring approaches that activate the heart through its intrinsic conduction pathways.

News

Biogen will advance its tau-targeting Alzheimer's disease drug diranersen into phase 3, even though it missed the main endpoint in a midstage trial.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.